# CINCINNATI CHILDRENS HOSP MED CTR: Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | CINCINNATI CHILDRENS HOSP MED CTR |
| Location | CINCINNATI, OH |
| Project | Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia |
| Project number | 3U01HL133883-10S3 |
| Mechanism | U01 |
| Institute | National Heart Lung and Blood Institute |
| Award | $196,803 |
| Awarded | 2026-08-28 |
| Project period | 2017-08-01 to 2027-07-31 |
| UEI | JZD1HLM2ZU83 |

## Why this score
- Award of $196,803.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11606511). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.